Saturday, January 23, 2021
US agency on Moderna vaccine
Allergic reaction to vaccine “rare”
According to the US health authority CDC, the vaccine from the manufacturer Moderna hardly causes severe allergic reactions. Of the four million doses injected, ten caused anaphylactic shocks. More women than men are allergic – this is not only the case with the Moderna vaccine.
Serious allergic reactions to the corona vaccine from the US company Moderna are “rare” according to the US health authority CDC. After administration of more than four million doses of the vaccine, so-called anaphylactic shocks occurred in only ten of the vaccine recipients, said the CDC. None of the allergic reactions resulted in death.
The CDC based its assessment on the documentation of a total of 4,041,396 vaccine doses administered between December 21, 2020 and January 10 this year. A total of 108 allergic reactions were found. In ten vaccine recipients, all of them women between the ages of 31 and 63, these reactions were therefore severe.
According to the CDC, nine of the women had a history of allergies, but they were not known to have any intolerance to vaccines. Nine of the women also had an allergic reaction within 15 minutes of injecting the Moderna vaccine. The tenth woman suffered from anaphylactic shock 30 minutes after she was given the vaccine. Six of the women reportedly had to be treated in hospital.
“The clinical and epidemiological characteristics of reports of anaphylactic shock following administration of Moderna’s Covid-19 vaccine are similar to those following administration of Biontech-Pfizer’s Covid-19 vaccine,” the CDC said. According to initial findings, more women than men reacted to the Biontech Pfizer vaccine. According to experts, however, this could also be due to the fact that significantly more women than men have been vaccinated against the coronavirus so far.
So far, the vaccines from Biontech-Pfizer and Moderna have been approved in Germany. A third will be added next week. It is a vaccine from the British-Swedish company Astrazeneca. This has already announced that it will be able to deliver fewer vaccine doses to the EU than previously planned. However, Federal Health Minister Jens Spahn was confident that many people could be vaccinated with the substance in February.